Spectroscopy® Names Ishan Barman 2019 Emerging Leader in Molecular Spectroscopy

HRS Scientific Sessions: Boston Scientific LBCT

During the Heart Rhythm Scientific Sessions this week, Boston Scientific announced positive LBCT data underscoring the safety and efficacy of multi-site pacing (MSP) over conventional cardiac resynchronization therapy (CRT), as well as poster presentations on real-world use of the WATCHMAN Left Atrial Appendage Closure (LAAC) device and next-generation WATCHMAN FLX LAAC device as alternatives to oral anticoagulation therapy for stroke risk reduction in patients with non-valvular atrial fibrillation.

What are the Most Commonly Performed Surgeries?

Whether you are trying to learn more about a surgery you are planning to have or find out what the most common procedures are, this list is here for you. Read more.

B2B Training: What’s the Most Effective Way of Learning?

B2B training, which is short for business-to-business training, is a popular and convenient type of training that enables entire companies to train their teams...

Spectroscopy® has announced they have awarded Ishan Barman, PhD, the 2019 Emerging Leader in Molecular Spectroscopy. The annual award recognizes the achievements and aspirations of a talented young molecular spectroscopist.

“We are honored to recognize Dr. Barman for this year’s Emerging Leader in Molecular Spectroscopy,” said Tom Ehardt, president of MultiMedia Healthcare, LLC. “Dr. Barman shows incredible passion, commitment and contribution to the spectroscopy research field.”

Barman is an assistant professor in the department of mechanical engineering at Johns Hopkins University, with joint appointments in the departments of oncology and of radiology and radiological Science. He is also a senior investigator of the National Institutes of Health-funded Laser Biomedical Research Center. He graduated from Indian Institute of Technology Kharagpur and then moved on to Massachusetts Institute of Technology, where he investigated transcutaneous blood analyte detection using Raman spectroscopy and received his doctorate.

His laboratory’s research focuses on the development of cutting-edge and transformative biophotonics technologies with the goal of disease detection at early, manageable stages; monitoring therapeutic effects and treatment outcomes; and guiding interventions. Specifically, Barman’s work features spectroscopic imaging, which combines the molecular basis of spectroscopy with the imaging capabilities of microscopy and bridges the chemical and morphologic domains.

The 2019 Emerging Leader in Molecular Spectroscopy Award will be presented to Barman at the SciX 2019 Conference in October. He will also give a plenary lecture and an outlook into his research.

Selected by an independent scientific committee, the Emerging Leader in Molecular Spectroscopy Award honors a young molecular spectroscopist who has made strides early in his or her career toward the advancement of molecular spectroscopy techniques and applications. The winner must be within 10 years of receiving his or her highest academic degree.

Specroscopy is a multimedia platform that promotes the use of spectroscopic instrumentation in applied research, environmental testing, quality control, and the life sciences



Mediclinic Appoints 2 New Independent Non-Executive Directors

Natalia Barsegiyan and Zarina Bassa will bring significant and diverse skills and experience, complementing those of existing Board members. I am confident they will both be great additions to our Board of Directors.”

Asensus Surgical Appoints Two New Board Members

Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced the expansion of its Board of Directors, appointing...

Our Sister Publication: Biotechnology News Magazine

Subscribe to Medical Device News Magazine here.